Telemedicine and the Prescribing of Controlled Substances After the End of The Covid-19 Pandemic Emergency: DEA Announces Two Significant Proposed Rules: Read the Summary Below, But Learn All the Details and More at HPM’s Webinar on March 23, 2023 (Details Forthcoming….)
FDA Law Blog
FEBRUARY 27, 2023
While no “special registration” will yet be required to engage in telemedicine prescribing of controlled substances, DEA is proposing parameters to guide the practice of telemedicine encounters in a post-COVID world. We will release exciting details of our upcoming webinar addressing telemedicine soon. 21 U.S.C. § 802(54)(D)(i).
59 
Let's personalize your content